Asst Dean of Student Affairs- University of Arizona College of Medicine, Director Inflammatory and Aging Skin Research Program-past-UofA, HarvardDerm, UCSF
Announcing:
The Geriatric Dermatology Society
https://t.co/8iUP580sAo
Thanks to leadership from medical student lead Shreya Sreekantaswamy from @UofUMedicine
We hope this serves as a collaborative platform for research, clinical, educational advancement. #dermtwitter
Test Your Knowledge, Team Trivia Starts Tomorrow! Join us for an interactive symposium on IL-13 inhibitors in #atopicdermatitis, with @nationaleczema. Compete in real-time case discussions & expert panels, @drshawnkwatra and @DanielButlerMD https://t.co/OVcbPIwK1H
Menopause and Eczema
Menopause is an excellent example of how age influences the skin via multiple systems. Thanks to the National Eczema Association for highlighting this critical population.
https://t.co/ZSJZPT4vnD
I was thrilled to join PALTtalk with Caring to discuss an important, yet often overlooked issue: chronic itch in older adults. It's a condition that deserves more attention, and I’m excited to help shed light on it.
Listen now: https://t.co/xZ8r6VZv4P
BIG NEWS! The Allen Discovery Center for Neuroimmune Interactions with @CellSymposia will co-host the next Neuro-immune axis symposium on September 7-9, 2025 in NYC! Keynotes include @NobelPrize recipient David Julius and @salkinstitute@Tcellogic.
https://t.co/kVecbPxW3j
Residency application season has officially begun. For those in leadership, remember to look for potential.
We tend to tag trainees as "good" or "not good" and subsequently differentiate and project their career.
Don't project a future; coach it.
Atopic Dermatitis therapeutics are moving fast! Recent developments:
- New IL13 on the market with lebrikizumab's FDA approval
- Tralokinumab autoinjector now available, decreasing the number of injections by 50%
These are all benefits for our patients.
Exciting to see innovation for diseases of older populations in dermatology.
It’s about time.
Efficacy and safety of low-dose Interleukin-2 in the treatment of moderate to severe bullous pemphigoid: https://t.co/7T1eAyXf2t
All credit for this project goes to @JayaManjunath1
and our Geriatric Dermatology ERG @AADskin
Jaya is a 4th year and a world leader in Geriatric Dermatology. We hope this provides practical tips to approach tough conversations that NEED to happen.
@TheDermEditor
3 out of every 10 USMD students applying to dermatology didn’t match. And this is a field where you need 15+ publications just to get an interview. Brutal.
3 out of every 10 USMD students applying to dermatology didn’t match. And this is a field where you need 15+ publications just to get an interview. Brutal.
Dr. John Barbeiri (@DrJohnBarbieri) has made significant contributions to dermatology, especially regarding the recent benzene issue. His efforts in engaging both experts and the public on this critical topic have been truly impactful. Let's honor his outstanding work by nominating him for the 'Member Making a Difference' award!
https://t.co/jA8HUy81Ho"
@AADmember@JAADjournals
Dr. John Barbeiri (@DrJohnBarbieri) has made significant contributions to dermatology, especially regarding the recent benzene issue. His efforts in engaging both experts and the public on this critical topic have been truly impactful. Let's honor his outstanding work by nominating him for the 'Member Making a Difference' award!
https://t.co/jA8HUy81Ho"
@AADmember@JAADjournals